Published in Oncologist on April 28, 2009
Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations. Oncologist (2015) 0.99
Impact of prior cancer on eligibility for lung cancer clinical trials. J Natl Cancer Inst (2014) 0.97
Cancer patient perceptions about biobanking and preferred timing of consent. Biopreserv Biobank (2014) 0.96
Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study. Trials (2012) 0.94
Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual. J Natl Cancer Inst (2015) 0.94
Consent timing and experience: modifiable factors that may influence interest in clinical research. J Oncol Pract (2011) 0.89
Learning from experience. Oncologist (2009) 0.75
Thoracic oncology clinical trial eligibility criteria and requirements continue to increase in number and complexity. J Thorac Oncol (2017) 0.75
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. N Engl J Med (2015) 12.54
Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell (2009) 6.16
Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell (2012) 4.37
ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature (2012) 3.44
Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc (2010) 3.25
Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer. J Clin Oncol (2011) 3.12
Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med (2013) 2.96
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS One (2009) 2.79
Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer. J Clin Oncol (2011) 2.69
Image-based genome-wide siRNA screen identifies selective autophagy factors. Nature (2011) 2.58
Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res (2010) 2.54
Targeted zwitterionic near-infrared fluorophores for improved optical imaging. Nat Biotechnol (2013) 2.44
Enhanced identification and biological validation of differential gene expression via Illumina whole-genome expression arrays through the use of the model-based background correction methodology. Nucleic Acids Res (2008) 2.11
Lung cancer diagnostic and treatment intervals in the United States: a health care disparity? J Thorac Oncol (2009) 1.82
Enhancing communication between oncologists and patients with a computer-based training program: a randomized trial. Ann Intern Med (2011) 1.78
Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy. Mol Cancer Ther (2011) 1.74
The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife (2012) 1.69
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. PLoS One (2010) 1.69
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A (2013) 1.67
Comparison of tailored interventions to increase mammography screening in nonadherent older women. Prev Med (2003) 1.64
Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev (2004) 1.62
Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations. Mol Cancer Res (2013) 1.57
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma. Dis Model Mech (2009) 1.53
Sociocultural correlates of breast cancer knowledge and screening in urban African American women. Am J Public Health (2003) 1.53
Comparing statistical methods for constructing large scale gene networks. PLoS One (2012) 1.49
Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila) (2012) 1.49
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction. Mult Scler (2013) 1.47
A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients. Clin Cancer Res (2013) 1.46
A breast cancer fear scale: psychometric development. J Health Psychol (2004) 1.45
R-Spondin potentiates Wnt/β-catenin signaling through orphan receptors LGR4 and LGR5. PLoS One (2012) 1.44
Pain predicts non-adherence to pap smear screening among middle-aged African American women. Prev Med (2005) 1.43
Responses to behaviorally vs culturally tailored cancer communication among African American women. Am J Health Behav (2004) 1.42
Development of a self-efficacy scale for mammography. Res Nurs Health (2005) 1.40
27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell Rep (2013) 1.39
Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol Biomarkers Prev (2005) 1.39
Studying communication in oncologist-patient encounters: the SCOPE Trial. Palliat Med (2006) 1.37
A randomized trial of two print interventions to increase colon cancer screening among first-degree relatives. Patient Educ Couns (2008) 1.36
Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study. BMC Complement Altern Med (2012) 1.35
A cost-effectiveness comparison of three tailored interventions to increase mammography screening. J Womens Health (Larchmt) (2004) 1.31
Stigma among patients with lung cancer: a patient-reported measurement model. Psychooncology (2013) 1.30
Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene. Cancer Res (2008) 1.28
Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev (2004) 1.27
Integrative analysis of multiple cancer prognosis studies with gene expression measurements. Stat Med (2011) 1.27
Coupling the Level-Set Method with Molecular Mechanics for Variational Implicit Solvation of Nonpolar Molecules. J Chem Theory Comput (2009) 1.23
The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res (2009) 1.22
Comparisons of tailored mammography interventions at two months postintervention. Ann Behav Med (2002) 1.22
Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation. Cancer Res (2010) 1.20
Differences in perceptions of risk, benefits, and barriers by stage of mammography adoption. J Womens Health (Larchmt) (2003) 1.20
BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer. Mol Cancer Ther (2013) 1.19
Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer. PLoS Med (2010) 1.19
Nematic electronic structure in the "parent" state of the iron-based superconductor Ca(Fe(1-x)Co(x))2As2. Science (2010) 1.18
Targeted therapies for lung cancer: clinical experience and novel agents. Cancer J (2011) 1.17
Expression profiling of nuclear receptors in human and mouse embryonic stem cells. Mol Endocrinol (2009) 1.16
Modified posterior soft tissue repair for the prevention of early postoperative dislocation in total hip arthroplasty. Int Orthop (2013) 1.13
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation. Cancer Res (2010) 1.13
Triangulating differential nonresponse by race in a telephone survey. Prev Chronic Dis (2007) 1.13
SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner. Cancer Res (2011) 1.13
Promoting colorectal cancer screening discussion: a randomized controlled trial. Am J Prev Med (2013) 1.13
The cost effectiveness of 5 interventions to increase mammography adherence in a managed care population. Am J Manag Care (2003) 1.11
Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse population. J Thorac Oncol (2010) 1.10
Sociocultural characteristics and responses to cancer education materials among African American women. Cancer Control (2003) 1.09
Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation. Cancer Res (2010) 1.09
Finding the minimal intervention needed for sustained mammography adherence. Am J Prev Med (2010) 1.09
Tumor mRNA expression profiles predict responses to chemotherapy. J Clin Oncol (2007) 1.08
Analysis of pleiotropic transcriptional profiles: a case study of DNA gyrase inhibition. PLoS Genet (2006) 1.08
The effect of telephone versus print tailoring for mammography adherence. Patient Educ Couns (2006) 1.08
Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics. Vaccine (2011) 1.08
Development and validation of a primary care-based family health history and decision support program (MeTree). N C Med J (2013) 1.07
Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma. Clin Cancer Res (2013) 1.07
Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy. Clin Cancer Res (2011) 1.06
Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA. Brief Bioinform (2014) 1.06
Computer-delivered tailored intervention improves colon cancer screening knowledge and health beliefs of African-Americans. Health Educ Res (2012) 1.06
Increasing colorectal cancer screening among individuals in the carpentry trade: test of risk communication interventions. Prev Med (2005) 1.05
Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations. J Thorac Oncol (2014) 1.04
Informing cancer prevention strategies for African Americans: the relationship of African American acculturation to fruit, vegetable, and fat intake. J Behav Med (2005) 1.03
A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma. Lung Cancer (2012) 1.03
Impact of routine cavity shave margins on breast cancer re-excision rates. Ann Surg Oncol (2010) 1.03
PIPE-CLIP: a comprehensive online tool for CLIP-seq data analysis. Genome Biol (2014) 1.03
Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes. Biochem Biophys Res Commun (2013) 1.01
Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer. Mol Endocrinol (2012) 1.01
Breast cancer risk perception and lifestyle behaviors among White and Black women with a family history of the disease. Cancer Nurs (2009) 1.01
Demographic and urodynamic factors associated with persistent OAB after anterior compartment prolapse repair. Neurourol Urodyn (2010) 1.01
Factors associated with annual-interval mammography for women in their 40s. Cancer Epidemiol (2009) 0.99
Health belief model variables as predictors of progression in stage of mammography adoption. Am J Health Promot (2007) 0.98
Predicting the future for people with lung cancer. Nat Med (2008) 0.97
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. J Thorac Oncol (2015) 0.97
A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871. Clin Cancer Res (2007) 0.96
Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer. Clin Lung Cancer (2013) 0.96
dCLIP: a computational approach for comparative CLIP-seq analyses. Genome Biol (2014) 0.95
Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study. J Ethnopharmacol (2011) 0.95
Community events as viable sites for recruiting minority volunteers who agree to be contacted for future research. Contemp Clin Trials (2011) 0.95